[ESPR] QoQ Quarter Result on 31-Dec-2001 [#Q4]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
30-Dec-2001
Financial Year
2001
Quarter
31-Dec-2001 [#Q4]
Profit Trend
QoQ- -1.00%
YoY- -14.00%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 CAGR
Revenue 0 0 0 0 0 1 1 -
PBT -6,980 -7,824 -7,303 -6,344 -6,281 -6,325 -5,981 10.83%
Tax 177 888 314 -112 736 -454 -976 -
NP -6,980 -7,824 -7,303 -6,344 -6,281 -6,325 -5,981 10.83%
Tax Rate - - - - - - - -
Total Cost 6,980 7,824 7,303 6,344 6,281 6,326 5,982 10.82%
Ratio Analysis
30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -632,500.00 -598,100.00 -
Per Share
30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 CAGR
EPS -1.67 -1.87 -1.75 -1.57 -1.56 -1.70 -1.61 2.46%
EPS Diluted -1.67 -1.87 -1.75 -1.57 -1.56 -1.70 -1.61 2.46%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.